Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Vaneck Biotech ETF (BBH)
Vaneck Biotech ETF (BBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 498,799,500
  • Shares Outstanding, K 3,170
  • 60-Month Beta 0.85
Trade BBH with:
  • Price/Earnings ttm 14.02
  • Annual Dividend & Yield 0.75 (0.48%)
  • Most Recent Dividend 0.749 on 12/19/22
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 23.83% ( +1.01%)
  • Historical Volatility 19.81%
  • IV Percentile 21%
  • IV Rank 22.97%
  • IV High 38.90% on 05/09/22
  • IV Low 19.34% on 03/03/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 30
  • Open Int (30-Day) 56

Price Performance

See More
Period Period Low Period High Performance
1-Month
150.33 +4.67%
on 03/10/23
162.03 -2.89%
on 02/21/23
-5.95 (-3.64%)
since 02/17/23
3-Month
150.33 +4.67%
on 03/10/23
169.66 -7.26%
on 01/26/23
-4.68 (-2.89%)
since 12/20/22
52-Week
131.12 +20.01%
on 06/16/22
170.25 -7.58%
on 12/13/22
-4.55 (-2.81%)
since 03/18/22

Most Recent Stories

More News
How Are Biotech ETFs Reacting to Q4 Earnings Releases?

The latest earnings from some of the big biotech players came in at mixed this reporting season.

BIIB : 267.91 (+1.80%)
AMGN : 234.72 (+2.15%)
GILD : 79.46 (+2.78%)
IBB : 125.85 (+1.08%)
HZNP : 108.71 (-0.32%)
XBI : 76.78 (+0.37%)
BBH : 157.35 (+1.22%)
5 Least-Hurt Biotech ETFs of the Last Week

Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.

REGN : 759.25 (+1.55%)
BMY : 67.24 (+1.07%)
AMGN : 234.72 (+2.15%)
GILD : 79.46 (+2.78%)
IBB : 125.85 (+1.08%)
LABD : 20.56 (-0.58%)
BBH : 157.35 (+1.22%)
FBT : 150.88 (+0.96%)
PBE : 62.12 (+2.01%)
BBP : 48.66 (+0.68%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 157.35 (+1.22%)
AMGN : 234.72 (+2.15%)
GILD : 79.46 (+2.78%)
VRTX : 298.95 (+1.08%)
IBB : 125.85 (+1.08%)
XBI : 76.78 (+0.37%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 157.35 (+1.22%)
AMGN : 234.72 (+2.15%)
GILD : 79.46 (+2.78%)
VRTX : 298.95 (+1.08%)
IBB : 125.85 (+1.08%)
XBI : 76.78 (+0.37%)
How Are Biotech ETFs Reacting to Q3 Earnings Releases?

Biotech earnings have come in upbeat in the third quarter.

BIIB : 267.91 (+1.80%)
AMGN : 234.72 (+2.15%)
GILD : 79.46 (+2.78%)
IBB : 125.85 (+1.08%)
XBI : 76.78 (+0.37%)
BBH : 157.35 (+1.22%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 157.35 (+1.22%)
AMGN : 234.72 (+2.15%)
GILD : 79.46 (+2.78%)
VRTX : 298.95 (+1.08%)
IBB : 125.85 (+1.08%)
XBI : 76.78 (+0.37%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 157.35 (+1.22%)
AMGN : 234.72 (+2.15%)
GILD : 79.46 (+2.78%)
VRTX : 298.95 (+1.08%)
IBB : 125.85 (+1.08%)
XBI : 76.78 (+0.37%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 157.35 (+1.22%)
AMGN : 234.72 (+2.15%)
GILD : 79.46 (+2.78%)
VRTX : 298.95 (+1.08%)
IBB : 125.85 (+1.08%)
XBI : 76.78 (+0.37%)
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

BIIB : 267.91 (+1.80%)
AMGN : 234.72 (+2.15%)
GILD : 79.46 (+2.78%)
IBB : 125.85 (+1.08%)
XBI : 76.78 (+0.37%)
BBH : 157.35 (+1.22%)
Moderna ETFs Rallying on COVID-19 Vaccine Booster Shot Update

Moderna has been rallying on the latest positive booster shot-related update.

MRNA : 154.52 (+3.00%)
IBB : 125.85 (+1.08%)
BBH : 157.35 (+1.22%)
IDNA : 23.05 (unch)
GERM : 20.49 (-0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Key Turning Points

3rd Resistance Point 159.96
2nd Resistance Point 158.66
1st Resistance Point 158.00
Last Price 157.35
1st Support Level 156.04
2nd Support Level 154.74
3rd Support Level 154.08

See More

52-Week High 170.25
Last Price 157.35
Fibonacci 61.8% 155.30
Fibonacci 50% 150.68
Fibonacci 38.2% 146.06
52-Week Low 131.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar